Form 4: VolitionRx Chief Medical Officer Receives Stock Award in Lieu of Cash Compensation

VolitionRx's Chief Medical Officer, Andrew Retter, received 9,365 restricted stock units (RSUs) in lieu of cash compensation.

Summary

• Andrew Retter, the Chief Medical Officer of VolitionRx Ltd, was granted 9,365 restricted stock units (RSUs) on December 1, 2024.
• These RSUs were awarded in place of cash compensation that would have otherwise been paid to Mr. Retter.
• The RSUs vest in three installments of 3,122 units, 3,122 units, and 3,121 units on December 1, 2024, January 1, 2025, and February 1, 2025, respectively.
• The RSUs are also subject to further time-based vesting in a single installment on July 1, 2025.
• The vesting is contingent upon Mr. Retter's continued service with the company through each applicable vesting date.
• Upon vesting and settlement, Mr. Retter will receive shares of common stock equal to the number of vested RSUs.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally neutral to positive. The use of RSUs instead of cash is a positive for the company's cash flow.

Positives

• The use of RSUs instead of cash may help the company conserve cash resources.
• The vesting schedule incentivizes the Chief Medical Officer to remain with the company.

Risks

• The value of the RSUs is tied to the company's stock price, which can fluctuate.
• If the stock price declines, the value of the compensation will decrease.

Future Outlook

The reporting person will receive shares of common stock upon vesting of the RSUs, subject to continued service.

Industry Context

The use of stock-based compensation is a common practice in the biotechnology industry to attract and retain key personnel, especially in companies that may be in the early stages of development or have limited cash resources.

Comparison to Industry Standards

• Stock-based compensation is a common practice among publicly traded companies, particularly in the biotech sector, where cash resources may be limited.
• Companies like Exact Sciences (EXAS) and Guardant Health (GH) also use stock options and RSUs as part of their compensation packages for executives and employees.
• The vesting schedule of the RSUs is typical, with a mix of time-based vesting to incentivize long-term commitment.

Stakeholder Impact

• Shareholders may view the use of RSUs as a positive, as it conserves cash.
• Employees may see the stock-based compensation as a positive incentive.

Key Dates

Keywords

restricted stock units, RSUs, stock compensation, executive compensation, insider trading, VolitionRx, VNRX, Andrew Retter